Novi vs Zealthy: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Novi beats Zealthy overall, scoring 7.8/10 vs 7.2/10. Novi is more affordable at $133/mo vs $286/mo. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa. Choose Zealthy for users who want the option to switch between compounded and b.
A side-by-side comparison of Novi and Zealthy covering pricing, scores, medication types, insurance, and more to help you decide.
Novi
#14 of 46Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing — medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit NoviZealthy
#42 of 46Flexible GLP-1 provider allowing patients to switch between compounded and brand-name medications as needed.
Visit Zealthy| Feature | Novi | Zealthy |
|---|---|---|
| Our Score | 7.8/10 | 7.2/10 |
| Starting Price | $133/mo | $286/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer | Users who want the option to switch between compounded and brand-name GLP-1s |
| Ranking | #14 | #42 |
Pros & Cons Compared
Novi
Pros
- +Six disclosed clinicians on staff — Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP) — more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment — cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing — $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only — standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded — typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages — unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Zealthy
Pros
- +Dedicated insurance coordinators handle prior authorizations — potentially bringing brand-name GLP-1 costs to $25/mo
- +Multi-month supply options (3, 6, or 12 months) — unique convenience most monthly-shipping competitors can't match
- +Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection
- +LegitScript certified with 4.5-star Review.io rating
Cons
- −$135 membership fee on top of medication cost makes cash-pay total ~$286/mo for semaglutide — above average
- −Young company (founded 2023) with a relatively small review base — less track record than established platforms
- −Prescription products are non-refundable for any reason once ordered
Our Verdict
Novi edges out Zealthy with a score of 7.8/10 vs 7.2/10. If budget is your priority, Novi starts at $133/mo compared to Zealthy's $286/mo. Zealthy offers both brand-name and compounded medications, giving you more flexibility. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer. Choose Zealthy if you want: users who want the option to switch between compounded and brand-name glp-1s.